Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,912 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $520.52 | 25 | $0 (2024) |
| ABBVIE INC. | $322.59 | 12 | $0 (2024) |
| PFIZER INC. | $193.02 | 11 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $153.36 | 7 | $0 (2024) |
| Averitas Pharma Inc. | $118.34 | 3 | $0 (2023) |
| Vertos Medical, Inc. | $104.09 | 1 | $0 (2024) |
| Stimwave Technologies Incorporated | $93.45 | 2 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $87.69 | 4 | $0 (2022) |
| Merz Pharmaceuticals, LLC | $63.07 | 2 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $53.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $753.48 | 27 | Abbott Laboratories ($290.75) |
| 2023 | $573.65 | 27 | Abbott Laboratories ($130.87) |
| 2022 | $510.26 | 26 | Abbott Laboratories ($98.90) |
| 2021 | $75.00 | 1 | Stimwave Technologies Incorporated ($75.00) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Neuromodulation | ||||||
| 12/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/17/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: ORTHOPEDICS | ||||||
| 11/25/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuromodulation | ||||||
| 11/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Neuromodulation | ||||||
| 10/29/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: Neuromodulation | ||||||
| 10/17/2024 | Bioventus LLC | DUROLANE (Device) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ORTHOPEDICSORTHOPEDIC SURGERY | ||||||
| 10/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Neuromodulation | ||||||
| 09/19/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $119.22 | General |
| Category: Neuromodulation | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: PAIN | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/29/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Opioid Analgesic | ||||||
| 05/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Neuromodulation | ||||||
| 04/10/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Neuromodulation | ||||||
| 04/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: PAIN | ||||||
| 03/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Opioid Analgesic | ||||||
| 03/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Neuromodulation | ||||||
| 03/05/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $104.09 | General |
| Category: Orthopedic | ||||||
| 03/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PAIN | ||||||
| 01/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 928 | 2,003 | $714,348 | $155,562 |
| 2022 | 8 | 976 | 2,556 | $795,650 | $168,698 |
| 2021 | 5 | 365 | 571 | $175,061 | $39,301 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 387 | 1,142 | $428,316 | $87,476 | 20.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 142 | 253 | $151,800 | $48,403 | 31.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 109 | 161 | $44,200 | $9,210 | 20.8% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 196 | 323 | $66,000 | $7,705 | 11.7% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 35 | 46 | $18,255 | $1,617 | 8.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 59 | 78 | $5,777 | $1,152 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 329 | 1,030 | $384,046 | $80,363 | 20.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 119 | 245 | $147,000 | $47,296 | 32.2% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2022 | 306 | 855 | $173,000 | $23,059 | 13.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 122 | 264 | $70,460 | $15,631 | 22.2% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2022 | 29 | 38 | $14,452 | $1,255 | 8.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 43 | 61 | $4,422 | $914.29 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 17 | $2,040 | $159.22 | 7.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 14 | 46 | $230.00 | $19.87 | 8.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 252 | $93,337 | $21,352 | 22.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 37 | 44 | $26,400 | $8,560 | 32.4% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2021 | 131 | 213 | $42,600 | $6,428 | 15.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 37 | 44 | $11,440 | $2,692 | 23.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 17 | 18 | $1,284 | $269.28 | 21.0% |
About David Reavis, PA-C
David Reavis, PA-C is a Physician Assistant healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1306005681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Reavis, PA-C has received a total of $1,912 in payments from pharmaceutical and medical device companies, with $753.48 received in 2024. These payments were reported across 81 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,912).
As a Medicare-enrolled provider, Reavis has provided services to 2,269 Medicare beneficiaries, totaling 5,130 services with total Medicare billing of $363,560. Data is available for 3 years (2021–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Salem, OR
- Active Since 06/03/2008
- Last Updated 06/02/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1306005681
Products in Payments
- PROCLAIM (Device) $505.52
- NURTEC ODT (Drug) $213.84
- BOTOX (Biological) $130.49
- QUTENZA (Drug) $118.34
- QULIPTA (Drug) $109.59
- mild Device Kit (Device) $104.09
- UBRELVY (Drug) $97.18
- StimQ Receiver Stimulator Kit Channel A US w Receiver (Device) $75.00
- Xeomin (Biological) $63.07
- ELYXYB - celecoxib (Drug) $54.41
- RELISTOR (Drug) $53.85
- COMIRNATY (Biological) $51.18
- Belbuca (Drug) $44.35
- ZTLido (Drug) $43.55
- XTAMPZA (Drug) $39.05
- Qutenza (Drug) $38.41
- Iovera (Device) $34.44
- DUROLANE (Device) $20.03
- EUFLEXXA (Device) $19.15
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $18.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Salem
Shawn Hill, Mpas, MPAS
Physician Assistant — Payments: $16,101
Mrs. Olivia Darwin, Pa-C, PA-C
Physician Assistant — Payments: $9,122
Shannon Snyder, Pa-C, PA-C
Physician Assistant — Payments: $8,469
Eric Harmon, Pa, PA
Physician Assistant — Payments: $8,455
Robert Wollenzien
Physician Assistant — Payments: $7,551
Jordan Young, Pa-C, PA-C
Physician Assistant — Payments: $7,356